BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lawhn-heath C, Hope TA, Martinez J, Fung EK, Shin J, Seo Y, Flavell RR. Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose. The Lancet Oncology 2022;23:e75-87. [DOI: 10.1016/s1470-2045(21)00657-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ardenfors O, Nilsson JN, Thor D, Hindorf C. Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy. EJNMMI Phys 2022;9:44. [PMID: 35723797 DOI: 10.1186/s40658-022-00473-z] [Reference Citation Analysis]
2 Correa-Alfonso CM, Withrow JD, Domal SJ, Xing S, Shin J, Grassberger C, Paganetti H, Bolch WE. A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals. EJNMMI Phys 2022;9:28. [PMID: 35416550 DOI: 10.1186/s40658-022-00456-0] [Reference Citation Analysis]
3 Hope TA, Pavel M, Bergsland EK. Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time? J Clin Oncol 2022;:JCO2200176. [PMID: 35649195 DOI: 10.1200/JCO.22.00176] [Reference Citation Analysis]